Characterization of subspecies of apolipoprotein A-I-containing lipoprotein in homozygotes for familial lecithin:cholesterol acyltransferase deficiency
- PMID: 8018670
- DOI: 10.1161/01.atv.14.7.1137
Characterization of subspecies of apolipoprotein A-I-containing lipoprotein in homozygotes for familial lecithin:cholesterol acyltransferase deficiency
Abstract
We characterized the two species of lipoproteins containing apolipoprotein A-I (apoA-I), one containing only apoA-I (LpA-I) and the other containing apoA-I and apoA-II (LpA-I/A-II), in four homozygotes for familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Two homozygotes lacked both LCAT mass and activity, whereas the other two had some residual LCAT mass and activity. In these patients, the amount of all apoA-I-containing lipoproteins was one fourth that of normal control subjects, and > 60% was LpA-I. The chemical composition of both LpA-I and LpA-I/A-II is characterized by markedly decreased ratios of neutral to polar lipids compared with those of normals and the sizes of LpA-I and LpA-I/A-II particles are shifted to smaller and larger diameter ranges when compared with those of normal particles. Changes in particle diameter are also reflected in slower electrophoretic mobilities of both LpA-I and LpA-I/A-II particles. All of these abnormalities were more evident in the two homozygotes who lacked LCAT activity. Incubation of LCAT-deficient plasma with LCAT markedly corrected the chemical and physical abnormalities in both LpA-I and LpA-I/A-II particles. These data, taken together, emphasize the importance of LCAT in modifying the chemical composition, size, and shape of LpA-I and LpA-I/A-II particles.
Similar articles
-
Characterization of subspecies of lipoprotein containing apolipoprotein A-I in heterozygotes for familial lecithin:cholesterol acyltransferase deficiency.Atherosclerosis. 1995 Apr 24;114(2):147-55. doi: 10.1016/0021-9150(94)05478-2. Atherosclerosis. 1995. PMID: 7605383
-
Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.J Clin Invest. 1994 Jan;93(1):321-30. doi: 10.1172/JCI116962. J Clin Invest. 1994. PMID: 8282802 Free PMC article.
-
Evidence for impaired cellular cholesterol removal mediated by apo A-I containing lipoproteins in patients with familial lecithin: cholesterol acyltransferase deficiency.Biochim Biophys Acta. 1994 Aug 4;1213(3):295-301. Biochim Biophys Acta. 1994. PMID: 8049242
-
Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literature.J Clin Lipidol. 2011 Nov-Dec;5(6):493-9. doi: 10.1016/j.jacl.2011.07.002. Epub 2011 Aug 23. J Clin Lipidol. 2011. PMID: 22108153 Free PMC article. Review.
-
[LCAT (lecithin:cholesterol acyltransferase)].Rinsho Byori. 2001 Nov;Suppl 116:125-30. Rinsho Byori. 2001. PMID: 11797372 Review. Japanese.
Cited by
-
Sex dimorphism in serum lecithin: cholesterol acyltransferase and lipoprotein lipase activities in adult sickle cell anaemia patients with proteinuria.Indian J Clin Biochem. 2011 Jan;26(1):57-61. doi: 10.1007/s12291-010-0096-9. Epub 2010 Dec 29. Indian J Clin Biochem. 2011. PMID: 22211015 Free PMC article.
-
A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency.J Lipid Res. 2022 Mar;63(3):100169. doi: 10.1016/j.jlr.2022.100169. Epub 2022 Jan 20. J Lipid Res. 2022. PMID: 35065092 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous